Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Bicycle Therapeutics plc

< Previous 1 2 Next >
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Enhances Leadership Team with Key Appointments
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Participate in the SVB Securities Global Biopharma Conference
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Present End of Dose Escalation Data from Ongoing Phase I/II Study of BT8009 at the 2023 ASCO Genitourinary (GU) Cancers Symposium
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces Publication of Article in the Journal of Medicinal Chemistry Highlighting Preclinical Data from BT8009 Program
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT8009 Program in Molecular Cancer Therapeutics
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces BT5528 Phase I Dose Escalation Results in Patients with Advanced Solid Tumors
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
Bicycle Therapeutics Announces Publication of Article in Bioconjugate Chemistry, Describing an Extension of its Proprietary Technology Platform Based on Bicyclic Peptides
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS